All Articles

Kiniksa raises its 2026 ARCALYST forecast after a blowout quarter, using its financial strength to advance a pipeline aimed at redefining pericarditis care.

Schulich School of Business and CGI partner on an AI-powered certificate to address critical tech talent shortages and create new career pathways.

ThreatDown, the business-focused unit from Malwarebytes, has radically transformed its sales model, betting its future on a partner-first strategy.

Texas Instruments launches the TI-84 Evo, a faster, more powerful graphing calculator designed to keep students focused on math in a distraction-filled world.

With a massive Series A, Coultreon Biopharma is advancing a novel SIK3 inhibitor spun out of Galapagos to rival injectable blockbusters for autoimmune disease.

A new report shows 50% of founders fear AI disruption, while burnout and the timeless challenge of product-market fit continue to plague the startup world.

Strong performance in its Materials Group helped Avery Dennison surpass Q1 earnings, offsetting a slight downturn in its strategic Intelligent Labels division.

Private equity giant CD&R brings on industrialist Jim Lico, signaling a deep bet on operational expertise to capitalize on the tech-driven industrial boom.

A new report reveals 80% of security pros fear AI will cut jobs, while AI-powered malware and ransomware attacks continue to surge globally.

French broadcaster M6 defies a weak ad market with rising profits, driven by its booming M6+ streaming service and a high-stakes bet on the FIFA World Cup.

After a catastrophic environmental failure, a private firm known for reviving distressed assets is in exclusive talks to acquire Yukon's Eagle Gold Mine.

CX giant Foundever appoints Eppie Titong III as APAC COO, a strategic move to bolster regional operations and drive growth in a key global market.

A new four-ingredient liposome formula shows breakthrough results in skin health, signaling a major shift for the cosmetic and nutraceutical markets.

As millions of owners prepare to sell, First Choice Business Brokers launches a national initiative to professionalize the high-stakes business sale process.

BRC Therapeutics gets the FDA green light for BRC-002, a novel cannabinoid drug for CRPS, a severe pain condition with no approved US treatments.

Alumnus Giuseppe Racanelli's landmark donation will rename a building and fund entrepreneurship, research, and crucial student mental health support.

A new survey reveals Canadian millennials are disciplined savers for their kids' education, but a staggering 'confidence gap' shows the toll of today's economy.

Pharma manufacturer Mikart cuts the ribbon on a new Atlanta HQ while boosting bottling capacity by 50%, tackling industry demand and fueling local growth.

The global book-sharing movement is launching a national celebration to fight 'book deserts' and strengthen neighborhood bonds one shared story at a time.

New research from industry veterans reveals five imperatives for B2B marketing leaders to become indispensable strategic drivers in the age of AI.